Full coverage· Health· Updated
Israel Recalls Similac Infant Formula Batch After Quality Complaint
Israel's Ministry of Health recalled a batch of Similac infant formula distributed only to hospitals due to a quality complaint. Separately, the ministry warned against the weight-loss product G-Slim after finding dangerous levels of sibutramine, which caused a consumer to seek emergency care.
10 newsrooms · 4 languages · sincePlus
What happened
- 01Israel recalls Similac infant formula batch 89203N201 from hospitals.
- 02The recall follows one quality complaint; no infant health issues reported.
- 03Manufacturer Abbott is replacing the affected batch.
- 04Ministry also warns against G-Slim weight-loss product.
- 05G-Slim contains high levels of banned sibutramine, posing health risks.
The coverage
10 newsrooms on this story
Who covered it
- LeftNone
- Centre2
- Right1
- Haredi1
- Arab1
- Other5
How it broke
See which of the 10 newsrooms broke it, and who waited